This federal contract award is for the delivery of BOOSTRIX TDAP vaccines in 0.5 mL syringes. The contract, valued at $1,329.55, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of December 10, 2024.
Generated 3/16/25, 12:51 AM